BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22840991)

  • 1. Autoantibodies in Sjögren's syndrome: clinical presentation and regulatory mechanisms.
    Tzioufas AG; Tatouli IP; Moutsopoulos HM
    Presse Med; 2012 Sep; 41(9 Pt 2):e451-60. PubMed ID: 22840991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review of autoantibodies in primary Sjögren's syndrome: clinical phenotypes and regulatory mechanisms.
    Kyriakidis NC; Kapsogeorgou EK; Tzioufas AG
    J Autoimmun; 2014 Jun; 51():67-74. PubMed ID: 24333103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren's syndrome--study of autoantigens and autoantibodies.
    Routsias JG; Tzioufas AG
    Clin Rev Allergy Immunol; 2007 Jun; 32(3):238-51. PubMed ID: 17992591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SSB/La antibodies in Sjögren's syndrome and related autoimmune diseases. Results of a quantitative immunoassay using a highly purified antigen.
    Montecucco C; Bestagno M; Cerino A; Caporali R; Carnevale R; Longhi M; Pedrini MA; Astaldi-Ricotti GC
    Clin Exp Rheumatol; 1989; 7(1):5-11. PubMed ID: 2495873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs).
    Tzioufas AG; Hantoumi I; Polihronis M; Xanthou G; Moutsopoulos HM
    J Autoimmun; 1999 Dec; 13(4):429-34. PubMed ID: 10585759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel autoantibodies in Sjögren's syndrome: A comprehensive review.
    Martín-Nares E; Hernández-Molina G
    Autoimmun Rev; 2019 Feb; 18(2):192-198. PubMed ID: 30572138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
    Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
    J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The autoantibody profile in Sjögren's syndrome].
    Manoussakis MN; Pange PJ; Moutsopulos HM
    Ter Arkh; 1988; 60(4):17-20. PubMed ID: 3260689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-centromere antibody-positive Sjögren's syndrome: A distinct clinical subgroup?
    Lee KE; Kang JH; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Lee SS
    Int J Rheum Dis; 2015 Sep; 18(7):776-82. PubMed ID: 26179502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunologic processes of the etiopathogenesis of Sjögren's syndrome].
    Oğüt MS; Ergüven S; Irkeç M; Gülmezoğlu E; Ustaçelebi S
    Mikrobiyol Bul; 1988 Jan; 22(1):30-5. PubMed ID: 3078788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
    Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
    Front Immunol; 2019; 10():1153. PubMed ID: 31191532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.
    Moutsopoulos HM; Zerva LV
    Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):123-30. PubMed ID: 2203591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.
    Davidson BK; Kelly CA; Griffiths ID
    Rheumatology (Oxford); 1999 Mar; 38(3):245-53. PubMed ID: 10325663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
    Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
    Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome.
    Hernández-Molina G; Leal-Alegre G; Michel-Peregrina M
    Autoimmun Rev; 2011 Jan; 10(3):123-5. PubMed ID: 20833272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
    Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
    Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.